// App-Quantinova.ai

591P : A PHASE IB STUDY OF EVEROLIMUS, 5-FLUOROURACIL (5-FU) AND PELVIC RADIOTHERAPY (RT) AS NEO-ADJUVANT TREATMENT FOR LOCALLY ADVANCED RECTAL CANCER (LARC)

Researchers

Presenter

  • F. Bertolini

Principal Investigators

  • E. Pettorelli

  • B. Meduri

  • S. Zironi

  • A. Fontana

  • F. Gelsomino

  • E. Mazzeo

  • R. Depenni

  • A. Spallanzani

  • P.F. Conte

  • G. Luppi

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

  • Pulmonary alveolar proteinosis

  • Solid malignancies

Biomarkers

  • C-C Motif Chemokine Ligand 20

  • Circulating tumor cells

Drug/Treatment

  • Adrucil injection

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved